Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberico

Showing results (51-60 of 1,039) with videos related to

Pageof 104
Sort By:
European Journal of Internal Medicine|November 3, 2021
One year after the ESC/EAS guidelines on cholesterol control. What's the new evidence? What's missing?Maurizio Averna, Alberico L Catapano
Current Atherosclerosis Reports|July 25, 2022
Inclisiran: How Widely and When Should We Use It?Angela Pirillo, Alberico Luigi Catapano
Atherosclerosis|November 2, 2015
Berberine, a plant alkaloid with lipid- and glucose-lowering properties: From in vitro evidence to clinical studiesAngela Pirillo, Alberico Luigi Catapano
European Heart Journal|June 6, 2018
PCSK9 inhibition and Lp(a) reduction: another piece of the puzzle?Angela Pirillo, Alberico Luigi Catapano
Drug Design, Development and Therapy|April 28, 2015
Update on the management of severe hypertriglyceridemia--focus on free fatty acid forms of omega-3Angela Pirillo, Alberico Luigi Catapano
Current Opinion in Lipidology|November 5, 2025
The two faces of cholesteryl ester transfer protein inhibitorsAngela Pirillo, Alberico L Catapano
Current Opinion in Endocrinology, Diabetes, and Obesity|January 4, 2022
New insights into the role of bempedoic acid and ezetimibe in the treatment of hypercholesterolemiaAngela Pirillo, Alberico L Catapano
European Heart Journal|August 14, 2021
Lipoprotein remnants: to be or not to beAngela Pirillo, Alberico Luigi Catapano
Atherosclerosis. Supplements|July 19, 2017
Pitavastatin and HDL: Effects on plasma levels and function(s)Angela Pirillo, Alberico L Catapano
High Blood Pressure & Cardiovascular Prevention : the Official Journal of the Italian Society of Hypertension|January 31, 2013
Global cardiovascular risk : the role of plasma lipidsAlberico L Catapano, Luca Catapano
Pageof 104

Showing results (51-60 of 1,039) with videos related to

Sort By:
Pageof 104
European Journal of Internal Medicine|November 3, 2021
One year after the ESC/EAS guidelines on cholesterol control. What's the new evidence? What's missing?Maurizio Averna, Alberico L Catapano
Current Atherosclerosis Reports|July 25, 2022
Inclisiran: How Widely and When Should We Use It?Angela Pirillo, Alberico Luigi Catapano
Atherosclerosis|November 2, 2015
Berberine, a plant alkaloid with lipid- and glucose-lowering properties: From in vitro evidence to clinical studiesAngela Pirillo, Alberico Luigi Catapano
European Heart Journal|June 6, 2018
PCSK9 inhibition and Lp(a) reduction: another piece of the puzzle?Angela Pirillo, Alberico Luigi Catapano
Drug Design, Development and Therapy|April 28, 2015
Update on the management of severe hypertriglyceridemia--focus on free fatty acid forms of omega-3Angela Pirillo, Alberico Luigi Catapano
Current Opinion in Lipidology|November 5, 2025
The two faces of cholesteryl ester transfer protein inhibitorsAngela Pirillo, Alberico L Catapano
Current Opinion in Endocrinology, Diabetes, and Obesity|January 4, 2022
New insights into the role of bempedoic acid and ezetimibe in the treatment of hypercholesterolemiaAngela Pirillo, Alberico L Catapano
European Heart Journal|August 14, 2021
Lipoprotein remnants: to be or not to beAngela Pirillo, Alberico Luigi Catapano
Atherosclerosis. Supplements|July 19, 2017
Pitavastatin and HDL: Effects on plasma levels and function(s)Angela Pirillo, Alberico L Catapano
High Blood Pressure & Cardiovascular Prevention : the Official Journal of the Italian Society of Hypertension|January 31, 2013
Global cardiovascular risk : the role of plasma lipidsAlberico L Catapano, Luca Catapano
Pageof 104